Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Pizarro-Gómez, C; Collado-Borrell, R; Escudero-Vilaplana, V; Massarrah, T; Revuelta-Herrero, JL; Calles, A; Alvarez, R; Villanueva-Bueno, C; Mur-Mur, A; Sánchez-Fresneda, MN; Herranz, A; Benedí-González, J; Martín, M; Sanjurjo, M.

Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2026; : [doi:10.1177/10781552251409387]

de Andrea, CE; Abengozar-Muela, M; Arranz, JA; Climent, MA; Puente, J; Vizcay, A; de la Fuente, LM; Jurado, JM; Bonfill, T; Santander, C; Villa, JC; Pujol, E; Rosero, AC; Gomez, J; Fernández, EM; Fernández, CA; Ramirez, I; Arnáiz, P; López-Janeiro, A; Melero, I; Sanmamed, MF; Pérez-Gracia, JL.

Association of PD-1, LAG-3 and TIM-3 expression on intratumoral CD8 T-cells with response to atezolizumab in a Real-World-Evidence biomarker study for advanced urothelial carcinoma patients

OncoImmunology. 2025; 14(1): [doi:10.1080/2162402X.2025.2538687]

Cerezuela-Fuentes, P; Piñero-Madrona, A; Muñoz-Couselo, E; Manzano, JL; Berciano-Guerrero, MA; Majem, M; Espinosa, E; Soria, A; de Miguel, PA; Castaño, AG; Crespo, G; Sanz, LG; de la Rosa, CA; Fernández-Morales, LA; Puértolas, T; Rodríguez, JF; de la Borbolla, MR; Bellido, L; Castro, RL; Pérez, VN; Arroyo, FRG; Guzmán, JCV; Balea, BC; Hernández, B; Algarra, SM; Márquez-Rodas, I.

Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801

CLINICAL & TRANSLATIONAL ONCOLOGY. 2025; : [doi:10.1007/s12094-025-04164-w]

Lopez-Jiménez, C; de Lucas, MB; de la Tabla, AGO; Alonso, NG; Arregui, M; Alvarez, R.

Primary Cardiac Sarcomas: Clinical Characteristics, Management, and Outcomes at a Spanish National Reference Center

Cancers. 2025; 17(24): [doi:10.3390/cancers17243947]

Salazar, J; Arranz, MJ; Martin-Broto, J; Serra, M; Palmerini, E; Martínez-García, J; Juan-Ribelles, A; Andion, M; Martinez-Trufero, J; Gutiérrez, G; Echebarria-Barona, A; Vaz-Salgado, MA; Regueiro, A; Alvarez, R; Valverde, C; Luna, P; Blay, P; Sebio, A.

VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol

Pharmaceuticals. 2025; 18(12): [doi:10.3390/ph18121855]

Jara, P; Ariant, M; Jiménez, R; Bringas, M; Herrero, B; Echavarría, I; Jerez, Y; Lopez-Tarruella, S; Márquez-Rodas, I; del Monte-Millán, M; Massarrah, T; de la Peña, FA; Martín, M.

Antitumor activity of the combination of vinorelbine and gemcitabine in patients with HR + /HER2-advanced breast cancer after CDK4/6 inhibitor

BREAST CANCER RESEARCH AND TREATMENT. 2025; 215(1): [doi:10.1007/s10549-025-07873-6]

Iglesias-Perez, C; Jimenez-Fonseca, P; Robles, JL; Adrián, SG; Pérez, IF; Prado, PMD; Pérez, JR; Castro, EMD; Pedroche, CD; Herreros, MGD; Campos, MC; Blanco, ABR; Fernández, MS; Verdúguez, TQ; González, DM; Rúa, MC; Crespo, JAS; Muñoz, MN; Muñoz, A; Carmona-Bayonas, A.

Venous thrombosis in lung cancer compared with other tumors: results from the TESEO-SEOM registry

THROMBOSIS RESEARCH. 2025; 256: [doi:10.1016/j.thromres.2025.109525]

Cerezuela-Fuentes, P; de la Rosa, CA; Crespo, G; Berciano-Guerrero, MA; Soria, A; Muñoz-Couselo, E; Castro, RL; Majem, M; de Miguel, PA; Manzano, JL; Bellido, L; Lecumberri, MJ; Subias, MC; Guzmán, JCV; Hernández, B; Espinosa, E; Puértolas, T; Sanz, LG; Martínez, JM; Abril, VP; Algarra, SM; Márquez-Rodas, I.

Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study

MELANOMA RESEARCH. 2025; 35(6): 399-408 [doi:10.1097/CMR.0000000000001062]

Radosa, JC; Cobo, SLT; Dzieran, J; Glastetter, E; Chen, C; Lingohr-Smith, M; Pasupuleti, V; Brufsky, A.

Palbociclib treatment in patients with HR+/HER2-advanced or metastatic breast cancer and visceral metastasis: A systematic literature review

BREAST. 2025; 84: [doi:10.1016/j.breast.2025.104569]

de la Peña, FA; Novoa, SA; Gregori, JG; Cortijo, LG; Carrasco, FH; Martínez, MTM; Estévez, CM; Stradella, A; Losada, MJV; Ciruelos, E.

SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (UPDATE 2025)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2025; : [doi:10.1007/s12094-025-04139-x]

Espinosa, E; Berciano-Guerrero, MA; Muñoz-Couselo, E; Puértolas, T; Manzano, JL; Soria, A; De Miguel, PA; Crespo, G; Sanz, LG; Cerezuela-Fuentes, P; de la Rosa, CA; Majem, M; Castaño, AG; Berrocal, A; Arroyo, FRG; de la Borbolla, MR; Bellido, L; Martínez, JM; Fernández, LA; Carnicero, AM; Castro, RL; Rodríguez, AB; Lecumberri, MJ; Guzmán, JCV; Balea, BC; Rodríguez, JF; Bautista, JV; Pérez, VN; Mujika, K; Subias, MC; Hernández, B; Algarra, SM; Márquez-Rodas, I.

Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801

CLINICAL & TRANSLATIONAL ONCOLOGY. 2025; : [doi:10.1007/s12094-025-04098-3]

Salgado, M; de la Camara-Gomez, J; García-Escobar, I; Alvarez-Llosa, RC; González-Villarroel, P; Garay, DF; Pàmpols-Felip, M; Guillot-Morales, M; Pelegrín-Mateo, FJ; Jimenez-Orozco, E; Sastre, J; De Castro, EM; Coma, E; Bouzas, LP; Ferrer-Pérez, AI; Mompradé-Olivé, E; Cousillas-Castiñeiras, A; Covela-Rúa, M; Rojas, M; Querol, R; Díaz, LR; Merino, M; Gil, M; Sánchez-Cánovas, M; Elías, T; Marrupe-González, D; Sánchez-Gil, B; Carmona-Campos, M; García-Ferron, M; Soria, JM; Muñoz, A.

Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design

BMC CANCER. 2025; 25(1): [doi:10.1186/s12885-025-14620-z]

Masini, S; Basa, MA; Calles, A; Cabellos, RA; Echebarria, ID; Puchol, CT; Kareaga, MM; Cabezon-Gutierrez, L; Perez, MCE; Lage, Y; Lorenzo, EG; Navarro, F; Sereno, M; Martínez, SF; García-Benito, C; Pinto, LM; Andrade, CA; Sequero, S; Martinez, JM; Lopez-Martín, A; Martínez, AA; Martín-Soberon, MC; Lucia-Gozalvez, C; Rubio, J; Tallafigo, L; Garrido, A; Peressini, M; Torres-Jimenez, J; Zurera, M; Bote, H; Ponce, S; Paz-Ares, L; Zugazagoitia, J; Baena, J.

Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression = 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study)

Cancers. 2025; 17(22): [doi:10.3390/cancers17223643]

Garcia-Saenz, JA; Lopez-Barajas, IB; Echavarria, I; Gonzalez, CH; Vila, MM; Antón, FM; Pernas, S; Cajal, TRY; Ribelles, N; Ezquerra, MB.

SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (UPDATE 2025)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2025; : [doi:10.1007/s12094-025-04102-w]

Smith, M; Piulats, J; Todenhöfer, T; Lee, JL; Arija, JA; Mazilu, L; Azad, A; Alonso-Gordoa, T; McGovern, U; Choudhury, A; Horvath, L; Ye, DW; Han, WQ; Suzuki, H; Uemura, H; Mckay, R; Ades, S; Fléchon, A; Pieczonka, C; Fernandes, MS; Hulstijn, M; Lithio, A; Nacerddine, K; Agarwal, N.

Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

LANCET ONCOLOGY. 2025; 26(11): 1489-1500 Nº de citas: 2

Lala, M; Bardia, A; Calles, A; Danesi, R; Freshwater, T; Healy, JA; Herbst, RS.

Weight-Based Pembrolizumab Dosing at 4 mg/kg Every 6 Weeks Leads to Exposures Below Approved Doses with Unestablished Efficacy: A Pharmacokinetic Model-Based Simulation Analysis

TARGETED ONCOLOGY. 2025; 20(6): 955-965 [doi:10.1007/s11523-025-01185-x]

Castet, F; Fabregat-Franco, C; Bridgewater, J; Kim, JW; Rimini, M; La Casta, A; Lamarca, A; Kang, MS; Salani, F; Castillo, A; Lopes, A; Hyung, J; Rimassa, L; Adeva, J; López-Valbuena, D; Basagaña-Farres, M; Vaja, S; Mak, KM; Tian, TV; Muñoz, A; Casadei-Gardini, A; DURVABTC Grp; Yoo, C; Valle, JW; Macarulla, T.

Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer

JOURNAL OF HEPATOLOGY. 2025; 83(5): [doi:10.1016/j.jhep.2025.05.020]

Rosa, AA; Carolina, AP; Marta, AV; Francisco, A; Adriana, FG; Natalia, G; Pablo, LL; Cristina, MF; Lidia, MS; Ulrike, N; Marina, S; Guillermo, HT; Henar, CG; Ana, GOD.

Desmoid Tumors-Experience from a Referral Center, Part 1: Multidisciplinary Review and Practical Recommendations

Cancers. 2025; 17(21): [doi:10.3390/cancers17213470]